"label","id","uuid:ID","instanceType","text","description","name"
"","Objective_1","737d32be-0677-403c-a77c-4ba4df65f28c","OBJECTIVE","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Main objective","OBJ1"
"","Objective_2","004fa10e-13be-4981-bfac-852340c34d5e","OBJECTIVE","To document the safety profile of the xanomeline TTS.","Safety","OBJ2"
"","Objective_3","9656d57e-6cf9-4ac8-ae03-0912758ad003","OBJECTIVE","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Behaviour","OBJ3"
